LRP6 mutation in a family with early coronary disease and metabolic risk factors

Science. 2007 Mar 2;315(5816):1278-82. doi: 10.1126/science.1136370.

Abstract

Coronary artery disease (CAD) is the leading cause of death worldwide and is commonly caused by a constellation of risk factors called the metabolic syndrome. We characterized a family with autosomal dominant early CAD, features of the metabolic syndrome (hyperlipidemia, hypertension, and diabetes), and osteoporosis. These traits showed genetic linkage to a short segment of chromosome 12p, in which we identified a missense mutation in LRP6, which encodes a co-receptor in the Wnt signaling pathway. The mutation, which substitutes cysteine for arginine at a highly conserved residue of an epidermal growth factor-like domain, impairs Wnt signaling in vitro. These results link a single gene defect in Wnt signaling to CAD and multiple cardiovascular risk factors.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Amino Acid Substitution
  • Animals
  • Chromosomes, Human, Pair 12 / genetics
  • Coronary Disease / genetics*
  • Coronary Disease / metabolism
  • Family Health
  • Female
  • Genetic Linkage
  • Genetic Predisposition to Disease*
  • Humans
  • LDL-Receptor Related Proteins / genetics*
  • LDL-Receptor Related Proteins / physiology
  • Lipids / blood
  • Low Density Lipoprotein Receptor-Related Protein-6
  • Male
  • Metabolic Syndrome / genetics*
  • Metabolic Syndrome / metabolism
  • Mice
  • Middle Aged
  • Mutation, Missense*
  • NIH 3T3 Cells
  • Osteoporosis / genetics
  • Pedigree
  • Risk Factors
  • Signal Transduction
  • Wnt Proteins / metabolism

Substances

  • LDL-Receptor Related Proteins
  • LRP6 protein, human
  • Lipids
  • Low Density Lipoprotein Receptor-Related Protein-6
  • Lrp6 protein, mouse
  • Wnt Proteins